Cancer survival in the U.S. has climbed to 70%, reflecting major advances in treatment, early detection and personalized care ...

Brazilian researchers have identified previously unknown forms of a protein linked to breast cancer. The discovery ...

Even with breakthroughs, treatment for advanced squamous cell carcinoma is more complex. Patients often need more than one treatment. Many patients with this advanced cancer are cared for by a team of ...

The FDA has accepted a New Drug Application (NDA) for Celcuity’s gedatolisib in hormone receptor positive (HR+), human ...

Cancer is still the most common cause of death for men in the US ages 60 to 79 and women ages 40 to 79. For all adults ...

Small intestine cancer occurs when abnormal cells grow in the tissues of the small bowel, the long tube that connects your ...

Dr. Benjamin Jon Golas of Hackensack Meridian Health discussed the main strategies for treating pancreas cancer, focusing on ...

Patients with severe melanoma who received the treatment were 49% less likely to die or have their cancer return, ...

There are several different types of radiation therapy. The type that may be recommended for you depends on a variety of factors, such as your cancer, its stage, and your treatment goals. Radiation ...

A clinical trial held at OU Health showed promising results for proton therapy for certain types of head and neck cancer.

Integration of targeted therapies and immunotherapies offers new hope, enhancing survival rates and quality of life. Patients with mantle cell lymphoma experienced better survival rates when treated ...

Gedatolisib's NDA for advanced breast cancer treatment has been accepted by the FDA, with a priority review and a PDUFA date ...